Clinical Trial Update: Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy [NA]

View source ↗

Summary

Completed trial update evaluating which supraesophageal reflux symptoms reliably respond to proton-pump inhibitor therapy in gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Proton Pump Inhibitor therapy

Snippet

Sponsor: Mayo Clinic | Conditions: Gastroesophageal Reflux | NA | Status: COMPLETED